As of August 31, 2026, AIM ImmunoTech Inc. (AIM) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. AIM ImmunoTech Inc. has a market capitalization of $4.50M, 8.15M shares outstanding, 7 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.82 below $1 exchange minimum
Market Data
Market Cap$4.50M
Shares Outstanding8.15M
Float7.99M
Cash$3.05M
Debt$4.90M
Short InterestN/A
Institutional Holdings
7 institutional holders · 242 shares
#1
Vanguard Group Inc
35 shares
#2
UBS Group AG
1 shares
#3
Geode Capital Management, LLC
34 shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track AIM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AIM — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for AIM
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.